Skip to content
Corex House

The Zimbabwean Government Declines ‘One-Sided’ US Healthcare Assistance Agreement Over Information Apprehensions

Health aid illustration
The proposed US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a significant US health deal worth $367m (272 million pounds) spanning five years because of the United States' request for confidential data.

The decision was revealed following a official document from December was leaked, which showed President Emmerson Mnangagwa felt the deal was "skewed".

A government spokesman has since stated that the US was demanding access to genetic material for scientific study and profit while was not willing to guarantee the resulting advantages from any future medical innovations.

"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged more talks to find a agreement acceptable to both sides so the nation's critical HIV programme can continue.

Wider Implications

Zimbabwe's decision comes after a similar case in Kenya, where a court suspended a related health funding agreement following concerns were filed about the safety of Kenyans' medical information.

After resuming office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance transparency and accountability.

According to statements, 16 African countries have so far signed similar agreements, constituting more than $18.3bn of fresh investment.

Details of the Rejected Agreement

This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to share its genetic material and health information over an extended period, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"In essence, our country would provide the basic resources for medical research with no assurance that the final treatments would be available to our people if a future disease outbreak arise."

Sovereignty and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures previously set up via the international health agency.

Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.

"This mechanism is intended to ensure that when a country provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome continued discussions with our US partners on how subsequent collaboration could be structured in a way that honours the independence and dignity of both nations."

Health Experts Response

Medical experts expressed it recognised the official position, but urged that negotiations should continue since much of the nation's HIV programmes relied on external financing.

"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," the group added.

This impasse underscores the ongoing tensions between receiving vital foreign assistance and safeguarding local interests in an increasingly interconnected world.

GS
Written by

Gabriela Schneider

A materials engineer with over 12 years of experience in plastic manufacturing and sustainable packaging solutions.

Corex House

Type to search articles.